au.\*:("MADELMONT, J. C")
Results 1 to 25 of 42
Selection :
Marquage par 14C de la triéthylamine = 14C labelling of triethylamineMADELMONT, J. C; GUERIN, P; DOMURADO, D et al.Journal of labelled compounds & radiopharmaceuticals. 1992, Vol 31, Num 9, pp 693-696, issn 0362-4803Article
Disposition in rat of a new fluorinated biocompatible, non-ionic telomeric carrierMAURIZIS, J. C; AZIM, M; RAPP, M et al.Xenobiotica (London. Print). 1994, Vol 24, Num 6, pp 535-541, issn 0049-8254Article
Main urinary metabolites of two cysteamine-containing 2-(chloroethyl) nitrosoureas in ratsGODENECHE, D; LABARRE, P; MOREAU, M. F et al.Drug metabolism and disposition. 1993, Vol 21, Num 1, pp 93-99, issn 0090-9556Article
Disposition in rats and mice of 7-methoxy-2-nitronaphtho [2,1-b] furanMAURIZIS, J. C; MADELMONT, J. C; PARRY, D et al.Xenobiotica (London. Print). 1985, Vol 15, Num 2, pp 141-148, issn 0049-8254Article
New cysteamine (2-chloroethyl)nitrosoureas. Synthesis and preliminary antitumor resultsMADELMONT, J. C; GODENECHE, D; PARRY, D et al.Journal of medicinal chemistry (Print). 1985, Vol 28, Num 9, pp 1346-1350, issn 0022-2623Article
Methionine dependency and cancer treatmentCELLARIER, E; DURANDO, X; VASSON, M. P et al.Cancer treatment reviews. 2003, Vol 29, Num 6, pp 489-499, issn 0305-7372, 11 p.Article
Disposition of stiripentol in the pregnant and non-pregnant female ratMAURIZIS, J. C; RAPP, M; MADELMONT, J. C et al.Xenobiotica (London. Print). 1993, Vol 23, Num 12, pp 1335-1343, issn 0049-8254Article
Metabolism of a new radioprotector; S-acetyl-N-glycyl cysteamine. II: Main tissue metabolites in mice bearing EMT6 tumoursMAURIZIS, J. C; MADELMONT, J. C; GODENECHE, D et al.Xenobiotica (London. Print). 1989, Vol 19, Num 8, pp 833-842, issn 0049-8254Article
Disposition of new sulphur-containing 2-(chloroethyl) nitrosoureas in ratsGODENECHE, D; MADELMONT, J. C; LABARRE, P et al.Xenobiotica (London. Print). 1987, Vol 17, Num 1, pp 59-70, issn 0049-8254Article
Nouvelle nitrosourée oncostatique d'utilisation clinique. II: Etude des constituants de la CNCC = New oncostatic nitrosouree of clinical use. II. Study of CNCC constituentsOIRY, J; POMPON, A; MADELMONT, J.-C et al.European journal of medicinal chemistry. 1984, Vol 19, Num 4, pp 311-314, issn 0223-5234Article
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adultsROCHE, H; CURE, H; ADENIS, A et al.Journal of neuro-oncology. 2000, Vol 49, Num 2, pp 141-145, issn 0167-594XConference Paper
Biodistribution and metabolism of orally administered mitozolomide in miceGACHON, F; LABARRE, P; GODENECHE, D et al.Drug metabolism and disposition. 1993, Vol 21, Num 4, pp 560-566, issn 0090-9556Article
Qualitative and quantitative analysis of a new sulphur-containing nitrosourea in blood by high-performance liquid chromatographyLABARRE, P; GODENECHE, D; MADELMONT, J. C et al.Journal of chromatography. 1987, Vol 419, pp 381-387, issn 0021-9673Article
Metabolism of 2-chloroethyl nitrosocarbamoylcystamine by rat liver subcellular fractionsGODENECHE, D; MADELMONT, J. C; MOREAU, M. F et al.Drug metabolism and disposition. 1986, Vol 14, Num 1, pp 112-117, issn 0090-9556Article
Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in ratsGODENECHE, D; MADELMONT, J. C; MOREAU, M. F et al.Drug metabolism and disposition. 1985, Vol 13, Num 2, pp 220-226, issn 0090-9556Article
Synthesis of a [99mTc] pharmacomodulated cyclam : A potential radiotracer for functional brain imagingBOREL, M; MOREAU, M.-F; VEYRE, A et al.Journal of labelled compounds & radiopharmaceuticals. 1998, Vol 41, Num 8, pp 755-761, issn 0362-4803Article
Radiosynthesis of no-carrier-added N-(4-dipropyl aminobutyl)-4-[125I]-iodobenzamide, a promising tracer for the detection of melanomaMOREAU, M. F; LABARRE, P; FOUCAUD, A et al.Journal of labelled compounds & radiopharmaceuticals. 1998, Vol 41, Num 10, pp 965-975, issn 0362-4803Article
Synthesis of 6-chloro 2(-ethylamino)-4-methyl-4-phenyl-[-4-14C]-4H,-3,1-benzoxazine (etifoxine)AZIM, E; DUPUY, J. M; LEPAGE, F et al.Journal of labelled compounds & radiopharmaceuticals. 1997, Vol 39, Num 11, pp 907-914, issn 0362-4803Article
Disposition and metabolism of O6-alkylguanine-DNA alkyltransferase inhibitor in nude mice bearing human melanomaCUSSAC, C; MOUNETOU, E; VEYRE, A et al.Drug metabolism and disposition. 1994, Vol 22, Num 4, pp 637-642, issn 0090-9556Article
Synthèse d'un télomère perfluorocarbone dérivé du tris(hydroxymethyl)14C et 13C-acrylamidomethane (F-TAC) = Synthesis of a perfluorocarbon telomer derived from 14C tris(hydroxymethyl) and 13C-acrylamidomethane (F-TAC)AZIM, M; MADELMONT, J. C; RAPP, M et al.Journal of labelled compounds & radiopharmaceuticals. 1994, Vol 34, Num 4, pp 307-311, issn 0362-4803Article
Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide)MICHELOT, J. M; MOREAU, M. F. C; PAPON, J. M et al.JNM. The journal of nuclear medicine (1990). 1993, Vol 34, Num 8, pp 1260-1266Article
Synthèse d'un télomère perfluorocarbone derivé du tris-(hydroxymethyl) 14C et 13C-acrylamidomethane (F-TAC) = Synthesis of a perfluorocarbon telomer, derived from tris(hydroxymethyl) 14C and 13C-acrylamidomethane (F-TAC)AZIM, M; MADELMONT, J. C; RAPP, M et al.Journal of labelled compounds & radiopharmaceuticals. 1993, Vol 33, Num 12, pp 1155-1159, issn 0362-4803Article
Marquage par 14C et 3H du 4,4-dimethyl-1-(methylendioxy-3,4 phenyl)-1-pentene-3- ol ou stiripentol = ↑1↑4C and ↑3H Labelling of 4,4-dimethyl-1-(methylenedioxy-3,4-phenyl)-1-pentene-3-ol or stiripentolMADELMONT, J. C; DUPUY, J. M; RAPP, M et al.Journal of labelled compounds & radiopharmaceuticals. 1992, Vol 31, Num 11, pp 961-966, issn 0362-4803Article
Marquage par 14C et 13C de la N acetyl O6 benzyl guanosine = Labelling by 14C and 13C of N-acetyl O6 benzyl guanosineMADELMONT, J. C; CUSSAC, C; VEYRE, A et al.Journal of labelled compounds & radiopharmaceuticals. 1992, Vol 31, Num 10, pp 793-800, issn 0362-4803Article
In vitro binding of oxime acetylcholinesterase reactivators to proteoglycans synthesized by cultured chondrocytes and fibroblastsMAURIZIS, J. C; OLLIER, M; NICOLAS, C et al.Biochemical pharmacology. 1992, Vol 44, Num 10, pp 1927-1933, issn 0006-2952Article